VIVA BIOTECH: (1) PROPOSED ADOPTION OF THE VIVA SHANGHAI PHASE I SHARE OPTION SCHEME AND THE VIVA SHANGHAI PHASE II SHARE OPTION SCHEME; AND (2) PROPOSED CONDITIONAL GRANT OF SHARE OPTIONS TO CONNECTED PERSONS AND OTHER PARTICIPANTS
Dec 22, 2023 06:53 ET
VIVA BIOTECH: COMPLETION OF MAJOR TRANSACTION IN RELATION TO THE DEEMED DISPOSAL OF EQUITY INTEREST IN A SUBSIDIARY AND AUTOMATIC CONVERSION OF CONVERTIBLE BONDS
Nov 20, 2023 04:14 ET
VIVA BIOTECH: COMPLETION OF THE CSRC POST-ISSUE FILING IN RELATION TO THE ISSUE OF CONVERTIBLE BONDS
Oct 25, 2023 06:50 ET
VIVA BIOTECH: COMPLETION OF ISSUE OF CONVERTIBLE BONDS UNDER GENERAL MANDATE
Jul 7, 2023 07:36 ET
VIVA BIOTECH: ISSUE OF CONVERTIBLE BONDS UNDER GENERAL MANDATE
Jun 11, 2023 06:49 ET
Viva Biotech Holdings: CANCELLATION AND GRANT OF SHARE OPTIONS
Jun 24, 2022 06:45 ET
Viva Biotech Holdings: RESET OF CONVERSION PRICE OF THE 2.50 PER CENT. GUARANTEED CONVERTIBLE BONDS DUE 2025 (THE "BONDS", STOCK CODE: 40144)
Feb 17, 2022 03:52 ET
Viva Biotech Holdings: GRANT OF SHARE OPTIONS
Dec 2, 2021 05:18 ET
Viva Biotech Holdings: SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO GRANT OF SHARE OPTIONS
Jul 9, 2021 07:46 ET
Viva Biotech Holdings: GRANT OF SHARE OPTIONS
Jul 7, 2021 07:13 ET
Viva Biotech Holdings: COMPLETION OF THE ACQUISITION OF THE ENTIRE EQUITY INTEREST IN SYNTHESIS MED CHEM (HONG KONG) LIMITED INVOLVING ISSUE OF CONSIDERATION SHARES UNDER GENERAL MANDATE
Mar 5, 2021 04:14 ET
Viva Biotech Holdings: MAJOR TRANSACTION IN RELATION TO THE ACQUISITION OF THE ENTIRE ISSUED SHARE CAPITAL IN SYNTHESIS MED CHEM (HONG KONG) LIMITED
Feb 25, 2021 03:32 ET
Viva Biotech Holdings: PROPOSED REFRESHMENT OF GENERAL MANDATE AND NOTICE OF EXTRAORDINARY GENERAL MEETING
Jan 31, 2021 05:04 ET
Viva Biotech Holdings: MAJOR TRANSACTION AMENDMENT OF THE SHARE TRANSFER AGREEMENT
Jan 25, 2021 06:48 ET
Viva Biotech Holdings: MAJOR TRANSACTION-GRANT OF WAIVER UNDER FROM STRICT COMPLIANCE WITH RULE 14.41(A) OF THE LISTING RULES, DELAY IN DISPATCH OF CIRCULAR AND TRANSACTION UPDATE
Jan 17, 2021 17:19 ET
Viva Biotech Holdings: COMPLETION OF THE ISSUE OF US$280 MILLION 1.00 PER CENT GUARANTEED CONVERTIBLE BONDS DUE 2025
Dec 30, 2020 06:57 ET
Viva Biotech Holdings: MAJOR TRANSACTION UPDATE ON POTENTIAL ISSUE OF CONSIDERATION SHARES
Dec 23, 2020 09:51 ET
Viva Biotech Holdings: PROPOSED ISSUE OF US$280 MILLION 1.00% GUARANTEED CONVERTIBLE BONDS DUE 2025
Dec 17, 2020 18:00 ET
Viva Biotech Holdings: MAJOR TRANSACTION FURTHER DELAY IN DISPATCH OF CIRCULAR, APPLICATION FOR A WAIVER UNDER RULE 14.41(A) OF THE LISTING RULES AND EXTENSION OF THE LONGSTOP DATE
Dec 15, 2020 09:09 ET
Viva Biotech Holdings: MAJOR TRANSACTION GRANT OF WAIVER FROM STRICT COMPLIANCE WITH RULE 14.41(A) OF THE LISTING RULES AND DELAY IN DISPATCH OF CIRCULAR
Oct 15, 2020 10:00 ET
No Data
No Data